-
Something wrong with this record ?
Interlobular Arteries From 2-Kidney, 1-Clip Goldblatt Hypertensive Rats' Exhibit-Impaired Vasodilator Response to Epoxyeicosatrienoic Acids
A. Sporková, RN. Reddy, JR. Falck, JD. Imig, L. Kopkan, J. Sadowski, L. Červenka,
Language English Country United States
Document type Journal Article
Grant support
NT14011
MZ0
CEP Register
- MeSH
- Renal Artery drug effects physiopathology MeSH
- Rats MeSH
- 8,11,14-Eicosatrienoic Acid analogs & derivatives pharmacology MeSH
- Kidney blood supply physiopathology MeSH
- Rats, Sprague-Dawley MeSH
- Hypertension, Renovascular drug therapy MeSH
- Vasodilation drug effects MeSH
- Vasodilator Agents pharmacology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Small renal arteries have a significant role in the regulation of renal hemodynamics and blood pressure (BP). To study potential changes in the regulation of vascular function in hypertension, we examined renal vasodilatory responses of small arteries from nonclipped kidneys of the 2-kidney, 1-clip Goldblatt hypertensive rats to native epoxyeicosatrienoic acids (EETs) that are believed to be involved in the regulation of renal vascular function and BP. A total of 2 newly synthesized EET analogues were also examined. MATERIALS AND METHODS: Renal interlobular arteries isolated from the nonclipped kidneys on day 28 after clipping were preconstricted with phenylephrine, pressurized and the effects of a 14,15-EET analogue, native 14,15-EET and 11,12-ether-EET-8ZE, an analogue of 11,12-EET, on the vascular diameter were determined and compared to the responses of arteries from the kidneys of sham-operated rats. RESULTS: In the arteries from nonclipped kidneys isolated in the maintenance phase of Goldblatt hypertension, the maximal vasodilatory response to 14,15-EET analogue was 30.1 ± 2.8% versus 49.8 ± 7.2% in sham-operated rats; the respective values for 11,12-ther-EET-8ZE were 31.4 ± 6.4% versus 80.4 ± 6%, and for native EETs they were 41.7 ± 6.6% versus 62.8 ± 4.4% (P ≤ 0.05 for each difference). CONCLUSIONS: We propose that reduced vasodilatory action and decreased intrarenal bioavailability of EETs combined with intrarenal angiotensin II levels that are inappropriately high for hypertensive rats underlie functional derangements of the nonclipped kidneys of 2-kidney, 1-clip Goldblatt hypertensive rats. These derangements could play an important role in pathophysiology of sustained BP elevation observed in this animal model of human renovascular hypertension.
Department of Biochemistry University of Texas Southwestern Medical Center Dallas Texas
Department of Pathophysiology 2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Pharmacology and Toxicology Medical College of Wisconsin Milwaukee Wisconsin
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17024020
- 003
- CZ-PrNML
- 005
- 20190919142308.0
- 007
- ta
- 008
- 170720s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.amjms.2016.02.030 $2 doi
- 035 __
- $a (PubMed)27140711
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sporková, Alexandra $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Electronic address: alhc@medicon.cz. $7 xx0239945
- 245 10
- $a Interlobular Arteries From 2-Kidney, 1-Clip Goldblatt Hypertensive Rats' Exhibit-Impaired Vasodilator Response to Epoxyeicosatrienoic Acids / $c A. Sporková, RN. Reddy, JR. Falck, JD. Imig, L. Kopkan, J. Sadowski, L. Červenka,
- 520 9_
- $a BACKGROUND: Small renal arteries have a significant role in the regulation of renal hemodynamics and blood pressure (BP). To study potential changes in the regulation of vascular function in hypertension, we examined renal vasodilatory responses of small arteries from nonclipped kidneys of the 2-kidney, 1-clip Goldblatt hypertensive rats to native epoxyeicosatrienoic acids (EETs) that are believed to be involved in the regulation of renal vascular function and BP. A total of 2 newly synthesized EET analogues were also examined. MATERIALS AND METHODS: Renal interlobular arteries isolated from the nonclipped kidneys on day 28 after clipping were preconstricted with phenylephrine, pressurized and the effects of a 14,15-EET analogue, native 14,15-EET and 11,12-ether-EET-8ZE, an analogue of 11,12-EET, on the vascular diameter were determined and compared to the responses of arteries from the kidneys of sham-operated rats. RESULTS: In the arteries from nonclipped kidneys isolated in the maintenance phase of Goldblatt hypertension, the maximal vasodilatory response to 14,15-EET analogue was 30.1 ± 2.8% versus 49.8 ± 7.2% in sham-operated rats; the respective values for 11,12-ther-EET-8ZE were 31.4 ± 6.4% versus 80.4 ± 6%, and for native EETs they were 41.7 ± 6.6% versus 62.8 ± 4.4% (P ≤ 0.05 for each difference). CONCLUSIONS: We propose that reduced vasodilatory action and decreased intrarenal bioavailability of EETs combined with intrarenal angiotensin II levels that are inappropriately high for hypertensive rats underlie functional derangements of the nonclipped kidneys of 2-kidney, 1-clip Goldblatt hypertensive rats. These derangements could play an important role in pathophysiology of sustained BP elevation observed in this animal model of human renovascular hypertension.
- 650 _2
- $a kyselina 8,11,14-eikosatrienová $x analogy a deriváty $x farmakologie $7 D015126
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a renovaskulární hypertenze $x farmakoterapie $7 D006978
- 650 _2
- $a ledviny $x krevní zásobení $x patofyziologie $7 D007668
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a arteria renalis $x účinky léků $x patofyziologie $7 D012077
- 650 _2
- $a vazodilatace $x účinky léků $7 D014664
- 650 _2
- $a vazodilatancia $x farmakologie $7 D014665
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Reddy, Rami N $u Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas.
- 700 1_
- $a Falck, John R $u Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas.
- 700 1_
- $a Imig, John D $u Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin.
- 700 1_
- $a Kopkan, Libor $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 xx0107287
- 700 1_
- $a Sadowski, Janusz $u Department of Renal and Body Fluid Physiology, M. Mossakowski Medical Research Centre, Polish Academy of Science, Warsaw, Poland.
- 700 1_
- $a Červenka, Luděk, $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Pathophysiology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic. $d 1967- $7 xx0037105
- 773 0_
- $w MED00000305 $t The American journal of the medical sciences $x 1538-2990 $g Roč. 351, č. 5 (2016), s. 513-519
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27140711 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20190919142659 $b ABA008
- 999 __
- $a ok $b bmc $g 1239701 $s 984933
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 351 $c 5 $d 513-519 $e 20160223 $i 1538-2990 $m The American journal of the medical sciences $n Am J Med Sci $x MED00000305
- GRA __
- $a NT14011 $p MZ0
- LZP __
- $a Pubmed-20170720
